Sellas Stock 346% Year Near Final REGAL Deaths Ahead
Sellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Explore which index funds have low turnover and how this characteristic can reduce tax drag, improving after-tax results for long-term investing.
27,549 articlesSellas Life Sciences has surged 346% over the past year as its REGAL trial for a WT1-targeting cancer vaccine moves t...
Independence Day grilling costs rise to a new peak for a 10-person cookout, underscoring how inflation is shaping hol...
Meta Platforms is catching the eye of value-focused investors. This guide breaks down why meta stock could most under...
As the July 1, 2026 MiCA deadline nears, EU regulators prepare to enforce licensing across crypto firms. Early moves ...
Airports face ongoing delays as spring travel returns. Enrolling in TSA PreCheck may help speed security lines for ti...
A blowout quarter sent AeroVironment stock soaring, but the bigger question for investors is whether the drone boom h...
Credit conditions are tightening ahead of any Fed move, driven by higher bond yields and a wave of AI financing. Inve...
A 63-year-old divorcee discovers that her ex-husband’s younger age blocks her ability to claim Social Security on his...
When margins rebound in the energy sector, even senior executives may trim holdings to align with evolving risk and o...
A legendary investor bets on a familiar retailer. This guide shows how to spot similar bargains, evaluate their upsid...
NVIDIA stock investors just received a wave of optimism from analysts who see substantial upside as AI adoption accel...
As AI spending hits record levels, Chamath Palihapitiya argues the real test is whether buyers of AI can deliver dura...